N10 Assets LLC Takes $7.21 Million Position in Danaher Corporation $DHR

N10 Assets LLC acquired a new position in shares of Danaher Corporation (NYSE:DHR) in the 2nd quarter, according to its most recent 13F filing with the SEC. The fund acquired 10,011 shares of the conglomerate’s stock, valued at approximately $7,208,000. Danaher comprises about 3.1% of N10 Assets LLC’s investment portfolio, making the stock its 13th largest holding.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Main Street Group LTD purchased a new position in Danaher during the first quarter worth $25,000. N.E.W. Advisory Services LLC acquired a new position in shares of Danaher in the second quarter worth $25,000. JPL Wealth Management LLC purchased a new stake in shares of Danaher in the third quarter valued at $25,000. WFA of San Diego LLC acquired a new stake in shares of Danaher during the second quarter valued at $26,000. Finally, Hilton Head Capital Partners LLC acquired a new stake in shares of Danaher during the fourth quarter valued at $27,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Stock Performance

NYSE DHR opened at $215.74 on Friday. The business’s 50-day moving average price is $198.69 and its 200 day moving average price is $192.35. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80. The company has a market capitalization of $151.67 billion, a PE ratio of 38.32, a price-to-earnings-growth ratio of 2.68 and a beta of 0.78.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, beating the consensus estimate of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The company had revenue of $6.26 billion during the quarter, compared to analysts’ expectations of $6.12 billion. During the same quarter in the previous year, the business earned $0.77 EPS. The firm’s revenue was up 5.5% on a year-over-year basis. On average, research analysts predict that Danaher Corporation will post 8.53 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on DHR. Evercore reissued an “outperform” rating and issued a $230.00 target price on shares of Danaher in a research note on Monday, July 6th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a $240.00 price target on shares of Danaher in a research note on Wednesday, July 22nd. Royal Bank Of Canada lifted their price target on shares of Danaher from $200.00 to $215.00 and gave the stock an “outperform” rating in a report on Wednesday, July 22nd. Wolfe Research lowered shares of Danaher from an “outperform” rating to a “peer perform” rating in a research report on Monday, June 1st. Finally, Wells Fargo & Company reduced their price objective on shares of Danaher from $212.00 to $195.00 and set an “equal weight” rating on the stock in a research note on Wednesday, July 22nd. One research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat.com, Danaher currently has an average rating of “Moderate Buy” and an average price target of $228.91.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.